フラックス・マターズ:IVIVCベースの,トランスダーマルのオキシブチニンに対するオクラージュ効果の予測
Kevin V Tobin1, Bianca Reginauld2, Dana C Hammell2
1Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD, USA.
The AAPS journal
|February 18, 2026
まとめ
新しいin vitro-in vivo相関モデル (IVIVC) は,オキシブチニン (OXB) の皮膚経吸収を予測し,薬物曝露と有害事象のリスクを大幅に増加させるオクラージュ効果を考慮しています.
科学分野:
- ファルマコキネティクスと薬物投与
- 皮膚および皮膚経由による薬物の吸収
- バイオ医薬品モデリング
背景:
- オキシブチニン (OXB) は,抗ムスカリニン剤であり,経口および経皮経路で過活性の膀を治療します.
- トランスダーマルのOXBは,オークルション下で著しく高い曝露 (15倍) を示し,有害事象の懸念を高めました.
- 経皮薬投与における閉塞に関連するリスクを理解し,軽減するために,予測モデルが必要です.
研究 の 目的:
- オキシブチニン (OXB) のトランスダーマルのin vitro-in vivo相関 (IVIVC) モデルを開発する.
- 開発されたIVIVCモデルを使用して,オークルション下でのOXB吸収と濃度を予測する.
- 閉塞を考慮したトランスダーマ IVIVC 発達の枠組みを確立する.
主な方法:
- 閉塞の有無でヒトの皮膚を用いたOXBゲルのインビトロ浸透性試験.
- 静脈内投与後の文献データを用いて,OXBの配置の特徴化.
- 閉塞した臨床試験のデータに対するデコンボリューション技術を用いた in vivo 吸収分析.
- IVIVCモデル内のインビトロおよびインビボフルスおよびオクラージョンパラメータの相関.
主要な成果:
- IVIVCモデルは,OXB濃度を正確に予測し,パラメータを正確に推定しました.
- 実験室内での流動は平均3.5時間の遅延を示したが,体内での流動は遅延を示さなかった.
- 皮膚の脱皮率の定数は,in vitro (0.17 h−1) とin vivo (0.16 h−1) で類似していました.
- In vivoオクラジウスは,オクラジウスを除去した後のOXBの曝露を18倍,除去後のOXBの曝露を30倍に増加させた.
結論:
- 開発されたIVIVCモデルは,オークルション下でのOXB濃度 in vivoを成功裏に予測しています.
- この研究は,オクラージュ効果を含む,皮膚経 IVIVC 開発のための新しい枠組みを確立しています.
- この発見は,皮膚経由の薬物行動を予測し,閉塞に関連するリスクを軽減する可能性を強調しています.
関連する概念動画
00:56One-Compartment Open Model for IV Bolus Administration: Estimation of Clearance
386
Clearance is a key pharmacokinetic parameter that quantifies the volume of body fluid from which a drug is entirely removed within a specific time frame. It is crucial in assessing how a drug is eliminated from the body and has critical clinical applications.
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
In the one-compartment open model for intravenous (IV) bolus administration, clearance is estimated by dividing the elimination rate by the plasma drug concentration. This equation leverages the elimination rate constant and the apparent...
386
01:19One-Compartment Open Model for IV Bolus Administration: General Considerations
787
The one-compartment model is a pharmacokinetic tool that models the body as a single, uniform compartment, facilitating the understanding of drug distribution and elimination. This model is particularly beneficial for intravenous (IV) bolus administration, where the drug rapidly circulates throughout the body.
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
The drug's presence in the body is defined by an equation representing the difference between the rates of drug entry and exit. Key parameters—elimination rate constant,...
787
01:18Two-Compartment Open Model: IV Bolus Administration
1.2K
The two-compartment model for intravenous (IV) bolus administration illustrates drug distribution in the body, subdividing it into central and peripheral compartments. This model operates on the concept of two-compartment kinetics. The drug's plasma concentration shows a bi-exponential decline following IV bolus administration, signaling the presence of two disposition processes: distribution and elimination.
The disparity between drug input and the sum of drug transfer rates between...
The disparity between drug input and the sum of drug transfer rates between...
1.2K
01:09One-Compartment Open Model for IV Bolus Administration: Estimation of Elimination Rate Constant, Half-Life and Volume of Distribution
941
The one-compartment open model is a simplified approach used in pharmacokinetics to understand the distribution and elimination of a drug administered through an intravenous bolus. This model assumes rapid drug dispersal throughout the body and elimination using a first-order process. Key pharmacokinetic parameters, such as the elimination rate constant (k), half-life (t1/2), and the apparent volume of distribution (Vd), can be estimated from this model. The elimination rate is calculated...
941
01:15One-Compartment Open Model for Extravascular Administration: First-Order Absorption Model
591
The first-order absorption model for extravascular administration describes the rate at which a drug is absorbed and eliminated, following the principles of first-order kinetics. This model is vital as it provides a mathematical representation of drug behavior within the body. It also allows for the prediction and interpretation of drug absorption and elimination based on the rate of change in drug concentration over time. This model can be visualized as a plasma concentration-time profile...
591
01:12One-Compartment Open Model for Extravascular Administration: Zero-Order Absorption Model
409
Extravascular administration, such as oral or intramuscular routes, is a non-invasive drug delivery method, often preferred for ease and patient compliance. A key factor here is absorption, which dictates how quickly and effectively the drug enters the bloodstream from the administration site. Absorption follows either zero-order or first-order kinetics.
Zero-order absorption maintains a steady rate irrespective of the amount of drug left to be absorbed, making it a constant process. In the...
Zero-order absorption maintains a steady rate irrespective of the amount of drug left to be absorbed, making it a constant process. In the...
409